Negative pressure wound therapy after abdominoperineal resection for lower rectal cancer
Official title: Evaluation of the Efficacy of Negative Pressure Wound Therapy on Perineal Healing Following Abdominoperineal Amputation
Run by Centre Hospitalier Departemental Vendee · NCT07489820 · Data updated 2026-11-12
This study tests whether using a negative pressure wound therapy dressing after abdominoperineal resection helps perineal healing in adults with lower rectal cancer who had preoperative chemoradiotherapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Centre Hospitalier Departemental Vendee Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 5 sites (Amiens and 4 other locations) |
| Status | Recruiting |
| Started | July 10, 2026 |
| Main results expected | July 15, 2029 |
| Study ends | July 15, 2029 |
| Registry record updated | July 20, 2026 |
| Trial ID | NCT07489820 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults planned for abdominoperineal resection for lower rectal cancer after neoadjuvant therapy and who can provide informed consent and are covered by social security.
✕Probably not a fit
Patients with contraindications to the PICO 7 dressing or with conditions like malignant wound bed involvement may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study examines direct perineal skin suturing with a PICO 7 negative pressure wound therapy dressing after abdominoperineal resection for non-metastatic adenocarcinoma of the lower rectum. Eligible participants are adults receiving the procedure after chemoradiotherapy and who can consent. The trial aims to see if the negative pressure dressing improves perineal wound healing compared with standard closure. Follow-up assesses wound healing outcomes and safety related to the dressing, within the surgical care pathway at multiple centers in France. The study does not specify a separate control group in the provided details and focuses on a specific dressing approach during perineal closure.
Why it matters
Potential benefit: If successful, patients may experience faster or more reliable perineal wound healing after abdominoperineal resection.
How similar studies have gone: Previous work in wound therapy suggests benefits of negative pressure dressings in complex abdominal wounds, but this specific approach after abdominoperineal resection is less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient; * Patient scheduled to undergo abdominoperineal resection for adenocarcinoma of the lower and very lower rectum following chemoradiotherapy (50 Gy over 5 weeks); * Patients capable of following the clinical trial protocol and who have provided written informed consent to participate in the clinical trial; * Patients enrolled in the social security system or eligible for coverage; Exclusion Criteria: * Patients scheduled to undergo a salvage abdominoperineal resection for squamous cell carcinoma following chemoradiotherapy; * Patients scheduled to undergo an abdominoperineal resection for adenocarcinoma of the very low rectum without neoadjuvant therapy; * Patients with a known allergy to the dressing; * Patients with a contraindication to the use of the PICO 7® dressing: * Malignancy within the wound bed or at the wound margins; * Previously confirmed, untreated osteomyelitis; * Non-enteric, unexplored fistulas; * Necrotic tissue with pressure ulcers; * Exposed arteries, veins, nerves, or organs; * Exposed anastomotic sites; * Patients participating in another clinical research protocol that could affect the objectives of this clinical trial; * Patients already randomized in this clinical trial; * Pregnant patients, women in labor, breastfeeding women, or women of childbearing age not using effective contraception\*; * Patients under guardianship, conservatorship, or deprived of their liberty; * Patients under an activated future protection order; * Patients under family authorization; * Patients under judicial protection.
Where it's running
-
Chd Vendee
La Roche-sur-Yon, France Recruiting -
Chu Amiens
Amiens, France Not yet recruiting -
Chu Angers
Angers, France Not yet recruiting -
Hospital Saint Antoine (Aphp)
Paris, France Not yet recruiting -
Chu Rennes
Rennes, France Not yet recruiting
Study contacts
- Principal investigator: Emeric ABET, Dr. — CHD Vendee
- Study coordinator: Agnès DORION
- Email: agnes.dorion@ght85.fr
- Phone: 2 51 44 63 80
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing trastuzumab deruxtecan (T‑DxD) for HER2‑positive advanced solid tumors
This will test whether trastuzumab deruxtecan (T‑DxD) helps adults in the US with HER2‑positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have had prior systemic treatment and have no satisfactory alternative options.
-
Bedside Spirometry to see if tidal volume matches ideal body weight in non-intubated ARDS
This pilot study tests whether tidal volume measured at bedside with high-flow oxygen and after NIV settings can help classify ARDS patients who are not intubated.
-
Laser treatment with two-year follow-up for pilonidal cysts
This project will see if laser surgery prevents pilonidal sinus recurrence within two years in adults who need the procedure.
-
Foot reflexology to reduce nausea after sleeve gastrectomy
This will try foot reflexology to see if it reduces nausea and vomiting in adults after sleeve gastrectomy.
-
Mental fatigue in surgeons during long operations
This study tests how mental fatigue affects surgeons performing digestive surgery and what factors contribute to it.
-
Personalised exercise support for people on hemodialysis.
This project will test whether personalised coaching from an adapted physical activity teacher together with an advanced practice nurse helps adults who recently started hemodialysis become more active than standard nurse support.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.